GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Phytohealth 4108.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

10.60

0.00%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 134.6m

FY2016FY2025

Net income

−TWD 58.2m

FY2016FY2025

Free cash flow

−TWD 45.3m

FY2016FY2025

Shareholders' equity

TWD 1.87bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 134.6mTWD 153.6mTWD 162.5mTWD 135.5mTWD 168.9mTWD 91.8mTWD 95.5mTWD 107.5mTWD 54.0mTWD 25.0m
Research and developmentTWD 119.3mTWD 128.5mTWD 92.6mTWD 119.5mTWD 120.5mTWD 124.7mTWD 164.1mTWD 168.0mTWD 146.1mTWD 161.6m
Operating income−TWD 174.6m−TWD 160.2m−TWD 121.7m−TWD 114.5m−TWD 95.2m−TWD 115.9m−TWD 204.6m−TWD 268.8m−TWD 268.4m−TWD 239.2m
Net income−TWD 58.2m−TWD 73.5m−TWD 47.1m−TWD 115.0m−TWD 78.0m−TWD 118.7m−TWD 170.9m−TWD 182.5m−TWD 206.3m−TWD 194.5m
Diluted earnings per share-0.28-0.37-0.24-0.58-0.43-0.72-1.00-1.05-1.19-1.13

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 2.35bnTWD 2.44bnTWD 2.35bnTWD 2.36bnTWD 2.47bnTWD 1.81bnTWD 1.88bnTWD 2.07bnTWD 2.19bnTWD 2.42bn
Cash and short-term investmentsTWD 1.07bnTWD 1.08bnTWD 1.27bnTWD 1.36bnTWD 1.41bnTWD 759.8mTWD 754.9mTWD 154.0mTWD 1.13bnTWD 1.34bn
Total liabilitiesTWD 59.4mTWD 71.3mTWD 79.8mTWD 87.2mTWD 81.6mTWD 107.5mTWD 130.2mTWD 123.5mTWD 114.7mTWD 109.6m
DebtTWD 15.7mTWD 18.3mTWD 28.1mTWD 30.2mTWD 30.9mTWD 17.3mTWD 15.8mTWD 541,000TWD 298,000—
Shareholders' equityTWD 1.87bnTWD 1.90bnTWD 1.93bnTWD 1.91bnTWD 1.98bnTWD 1.28bnTWD 1.30bnTWD 1.46bnTWD 1.68bnTWD 1.88bn
Shares outstanding206m198m199m199m183m165m171m174m173m173m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 39.7m−TWD 50.1m−TWD 54.8m−TWD 59.9m−TWD 68.2m−TWD 147.9m−TWD 121.4m−TWD 141.4m−TWD 151.5m−TWD 756.9m
Capital spending−TWD 5.5m−TWD 5.0m−TWD 4.9m−TWD 1.6m−TWD 13.2m−TWD 1.5m−TWD 7.0m−TWD 64.1m−TWD 32.9m−TWD 23.2m
Free cash flow−TWD 45.3m−TWD 55.2m−TWD 59.7m−TWD 61.6m−TWD 81.5m−TWD 149.4m−TWD 128.5m−TWD 205.5m−TWD 184.4m−TWD 780.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 35.9mTWD 34.5mTWD 33.1mTWD 39.9mTWD 31.0mTWD 30.5mTWD 37.0mTWD 39.8m
Operating income−TWD 38.9m−TWD 33.2m−TWD 42.1m−TWD 50.2m−TWD 48.7m−TWD 33.6m−TWD 29.6m−TWD 54.3m
Net income−TWD 6.1m−TWD 15.5m−TWD 17.0m−TWD 4.7m−TWD 21.9m−TWD 14.6m−TWD 18.6m−TWD 11.1m
Diluted earnings per share-0.03-0.08-0.08-0.02-0.11-0.07-0.09-0.06
Cash from operations−TWD 2.0m−TWD 17.0m−TWD 5.0mTWD 11.0m−TWD 15.0m−TWD 29.0m−TWD 2.0m−TWD 4.0m
Capital spending——−TWD 1.0m−TWD 2.0m−TWD 1.0m—−TWD 1.0m−TWD 3.0m
Free cash flow——−TWD 6.0mTWD 9.0m−TWD 16.0m—−TWD 3.0m−TWD 7.0m
Total assetsTWD 2.41bnTWD 2.29bnTWD 2.35bnTWD 2.34bnTWD 2.34bnTWD 2.40bnTWD 2.44bnTWD 2.46bn
Cash and short-term investmentsTWD 1.00bnTWD 1.00bnTWD 1.07bnTWD 1.18bnTWD 1.28bnTWD 1.30bnTWD 1.08bnTWD 1.36bn
DebtTWD 8.5mTWD 9.6mTWD 7.5mTWD 8.4mTWD 9.4mTWD 10.4mTWD 6.5mTWD 7.8m
Shareholders' equityTWD 1.94bnTWD 1.84bnTWD 1.87bnTWD 1.85bnTWD 1.85bnTWD 1.88bnTWD 1.90bnTWD 1.93bn

Financial ratios

Data as of 25 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-81.5%-70.5%-45.4%-84.5%-56.3%-126.4%
Net margin-43.2%-47.9%-29.0%-84.9%-46.2%-129.2%
Return on equity-3.1%-3.9%-2.4%-6.0%-3.9%-9.2%
Return on assets-2.5%-3.0%-2.0%-4.9%-3.2%-6.6%
Free cash flow yield-1.4%-1.9%-2.1%-2.5%-2.5%-7.5%
Revenue growth-12.4%-5.5%19.9%-19.8%84.0%-3.8%
Earnings growth-20.8%56.0%-59.0%47.4%-34.2%-30.6%
Current ratio27.41x24.02x26.13x25.25x28.78x12.44x
Debt to equity0.00x0.00x0.01x0.01x0.01x0.00x
Equity ratio79.6%77.9%82.0%80.7%80.2%70.9%
Interest coverage-291.85x-322.98x-214.54x-366.70x-234.84x-483.42x
R&D as a share of sales88.7%83.7%57.0%88.2%71.3%135.8%
Buybacks as a share of market value-3.8%0.2%0.0%-8.3%-11.0%3.2%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-0.2%7.9%20.4%
Operating income15.1%8.5%-4.1%
Net income-20.3%-13.3%-11.8%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-116.2%-97.4%-92.3%-176.5%
Net margin-45.7%-50.1%-57.9%-126.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-47.7-45.3-91.5-33.0-54.8-34.0-17.3-16.6-18.8-26.1
Price to sales20.621.726.528.025.343.931.028.271.9203.3

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.